Significant and Critical Accounting Policies and Practices (Tables)

9 Months Ended

Dec. 31, 2014

Schedule of Subsidiary of Limited Liability Company or Limited Partnership, Description [Table Text Block]

The Company's consolidated subsidiary and/or entity is as follows:

Name of consolidated subsidiary	State or other jurisdiction of	Date of incorporation or formation
or entity	incorporation or organization	(date of acquisition, if applicable)	Attributable interest

KoKo (Camden) Holdings (US), Inc.	Delaware	March 17, 2014	100%

Koko (Camden) Limited	United Kingdom	November 7, 2013	100%

Obar (Camden) Holdings Limited	United Kingdom	October 17, 2012	50%

Obar (Camden) Limited	United Kingdom	November 13, 2003	50%

Property, Plant and Equipment [Table Text Block]

Depreciation is computed by the straight-line method (after taking into account their respective estimated residual values) over the estimated useful lives of the respective assets as follows:

	Estimated Useful
	Life (Years)

Leasehold improvement		25

Furniture and fixtures		5

Production and entertainment equipment		10

Office equipment		5

Schedule of Differences between Reported Amount and Reporting Currency Denominated Amount [Table Text Block]

Translation of amounts from GBP into U.S. dollars has been made at the following exchange rates for the respective periods:

	December 31, 2014		March 31, 2014		December 31, 2013		March 31, 2013

Balance sheets		0.6437		0.6009		0.6064		0.6580

Statements of operations and comprehensive income (loss)		0.6082		0.6297		0.6381		0.6381

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

The Company’s contingent shares issuance arrangement, warrants are as follows:

	Contingent shares issuance
	arrangement, warrants
	For the		For the
	Reporting Period		Reporting Period
	Ended		Ended
	December 31,		December 31,
	2014		2013

Warrant Shares

Upon consummation of the reverse merger on April 28, 2014, the Company assumed the September 23, 2011 warrant to purchase 1,125,000 shares of the Company’s common stock with an exercise price of $0.15 per share expiring ten (10) years from date of issuance		1,125,000		-

Warrants to purchase 800,000 shares of the Company’s common stock with an exercise price of $0.01 per share expiring four (4) years from date of issuance on December 1, 2014		800,000		-

Total contingent shares issuance arrangement, warrants		1,925,000		-